Natural phytochemicals reverting M2 to M1 macrophages: A novel alternative leishmaniasis therapy
- PMID: 39863089
- DOI: 10.1016/j.micpath.2025.107311
Natural phytochemicals reverting M2 to M1 macrophages: A novel alternative leishmaniasis therapy
Abstract
Introduction: Leishmaniasis is a tropical parasitic disease caused by the protozoan Leishmania which remains a significant global health concern with diverse clinical manifestations. Transmitted through the bite of an infected sandfly, its progression depends on the interplay between the host immune response and the parasite. The disease outcome is linked to macrophage polarisation into M1 and M2 phenotypes. M1 macrophages are pro-inflammatory and promote parasite clearance, while M2 macrophages support tissue repair and parasite survival by facilitating promastigote entry and intracellular amastigote proliferation.
Purpose: The review focuses on discovering novel phytochemicals that exploit the immunomodulatory properties of macrophages, which can serve as an alternative antileishmanial treatments due to their diverse chemical structures and ability to modulate immune responses. It examines the immunomodulatory effects of phytochemicals that directly or indirectly promote antileishmanial activity by influencing macrophage polarisation and cytokine secretion. They can induce M1 macrophage polarisation to directly combat leishmaniasis or suppress M2 macrophages, thereby exerting indirect antileishmanial activity by influencing the release of M1-and M2-related cytokines.
Results & discussion: Phytochemicals demonstrate antileishmanial effects through ROS production, M1 activation, and cytokine modulation. They regulate M1/M2-related cytokines and macrophage activity, influencing immune responses. Although their effects may be non-specific, targeted delivery strategies could overcome current therapeutic limitations, positioning phytochemicals as promising candidates for leishmaniasis treatment to counter the limitations of current medications.
Keywords: Kala-azar; Leishmaniasis; M1 and M2 macrophages; Macrophage polarisation; Natural bioactive compounds.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare that no competing conflict of interest exists.
Similar articles
-
Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.PLoS Negl Trop Dis. 2015 May 29;9(5):e0003820. doi: 10.1371/journal.pntd.0003820. eCollection 2015 May. PLoS Negl Trop Dis. 2015. PMID: 26024228 Free PMC article.
-
Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles.Front Immunol. 2024 Aug 15;15:1437430. doi: 10.3389/fimmu.2024.1437430. eCollection 2024. Front Immunol. 2024. PMID: 39211053 Free PMC article. Review.
-
Chemopreventive Effects of Phytochemicals and Medicines on M1/M2 Polarized Macrophage Role in Inflammation-Related Diseases.Int J Mol Sci. 2018 Jul 28;19(8):2208. doi: 10.3390/ijms19082208. Int J Mol Sci. 2018. PMID: 30060570 Free PMC article. Review.
-
Macrophage Polarization in Leishmaniasis: Broadening Horizons.Front Immunol. 2018 Oct 31;9:2529. doi: 10.3389/fimmu.2018.02529. eCollection 2018. Front Immunol. 2018. PMID: 30429856 Free PMC article. Review.
-
Macrophage Polarization in the Skin Lesion Caused by Neotropical Species of Leishmania sp.J Immunol Res. 2021 Apr 10;2021:5596876. doi: 10.1155/2021/5596876. eCollection 2021. J Immunol Res. 2021. PMID: 33937417 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical